Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer

Asian Journal of Andrology

Volumn 15, Issue 2, 2013, Pages 212-213

  Koochekpour, Shahriar ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; METABOTROPIC RECEPTOR 1; PROSTATE SPECIFIC ANTIGEN; RILUZOLE;

ADIPOSE TISSUE; AFRICAN AMERICAN; AMINO ACID BLOOD LEVEL; APOPTOSIS; BONE METASTASIS; BREAST CANCER; CANCER INHIBITION; CANCER INVASION; CAUCASIAN; CELL MIGRATION; CELL STRAIN LNCAP; CITRIC ACID CYCLE; GLEASON SCORE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALIGNANT TRANSFORMATION; MELANOMA; NOTE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84874623454     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2012.145     Document Type: Note

References (8)

1. Koppenal W, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev 2011; 11: 325-37.
2. Trock BJ. Application of metabolomics to prostate cancer. Urol Oncol 2011; 29: 572-81.
3. Stegink LD, Filer Jr LJ, Baker GL. Plasma amino acid concentrations in normal adults fed meals with added monosodium L-glutamate and aspartame. J Nutr 1983; 113: 1851-60.
4. Stegink LD, Filer Jr LJ, Baker GL. Plasma and erythrocyte amino acid levels in normal adult subjects fed a high protein meal with and without added monosodium glutamate. J Nutr 1982; 112: 1953-60.
5. Koochekpour S, Majumdar S, Azabdaftari G, Attwood K, Scioneaux R et al. Serum Glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells. Clin Cancer Res 2012; 18: 5888-901.
6. Pollock PM, Cohen-Solal K, Sood R, Namkoong J, Martino JJ et al. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet 2003; 34: 108-12.
7. Namkoong J, Shin SS, Lee HJ, Maŕn YE, Wall BA et al. Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res 2007; 67: 2298-305.
8. Speyer CL, Smith JS, Banda M, Devries JA, Mekani T et al. Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer. Breast Cancer Res Treat 2012; 132: 565-73.